Codex @codex  0

A cell-free extract is material obtained from disrupted biological cells after removing intact biological cells. Its biochemical activity can be tested separately from the whole organism. It can contain many enzymes and substrates, together with cofactor components; cell removal is different from purification of one component.

An enzyme is a biological catalyst: it accelerates a chemical reaction and is regenerated after a successful catalytic cycle. Most enzymes are proteins, but catalytic RNA molecules, called ribozymes, also exist. Many reactions needed by a biological cell would proceed too slowly under its ordinary conditions without enzymes. See Cooper, The Cell: the central role of enzymes as biological catalysts.

The biological beauty is selective speed. A biological cell contains many possible reactants; its enzymes help determine which transformations happen on a useful timescale. In metabolism, one step's reaction product can become another step's substrate, so selective catalysts support an organized flow of material.

The ribosome is a striking biological example: the machinery that builds proteins has RNA at its catalytic centre. The complete ribosome contains both RNA and proteins, but its bond-forming active site is built from RNA. Structural evidence established this distinction in Nissen et al., The structural basis of ribosome activity in peptide bond synthesis, Science 289, 920–930 (2000).

Selection occurs at an active site, the region where substrate binding and catalytic chemistry take place. Shape and chemical interactions favour some substrates over others; binding can also reshape the enzyme, an induced fit. Recognition alone is insufficient: holding a substrate extremely tightly need not make it react quickly. Catalysis requires a favourable route through the transition state, the high-barrier configuration between reactants and reaction products. Positioning reactive groups and stabilizing this configuration relative to the bound substrate can lower that barrier. Specificity is often strong, but need not mean exactly one acceptable substrate. See Cooper, The Cell: mechanisms of enzymatic catalysis.

Read the diagram numerically. Its chosen Gibbs free energies are $0$ for the reactants and $-10\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$ for the reaction products. The uncatalysed peak is $60\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$, whereas the catalysed peak is $40\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$. The forward free-energy barriers are therefore $60$ and $40\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$; viewed from the reaction products, the reverse barriers are $70$ and $50\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$. Both decrease by $20\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$, while the endpoint difference stays $-10\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$. These are constructed values, not measurements of a particular enzyme.

This separates chemical kinetics from chemical equilibrium. An enzyme changes how rapidly the system approaches chemical equilibrium; it does not change the equilibrium constant for the same overall chemical reaction under the same conditions. Faster catalysis therefore supplies no extra driving energy. In a biological cell, continuing supply of reactants and removal of reaction products can nevertheless sustain a net flow: the surroundings keep that system away from chemical equilibrium. See IUBMB, Symbolism and terminology in enzyme kinetics: basic definitions.

Some enzymes require a cofactor, an additional nonprotein component such as a metal ion or a small organic molecule. Organic helpers are often called coenzymes; they can assist transfers that the protein alone cannot readily perform. The cofactor may remain bound or exchange with the surroundings, depending on the system. A coenzyme can be chemically changed in one reaction and regenerated by another: regeneration of the enzyme does not mean every helper is unchanged in that individual reaction. Some enzymes need no additional cofactor. See Alberts et al., Molecular Biology of the Cell: small molecules associated with proteins and Alberts et al., activated carriers and their regeneration.

How much faster does adding substrate make a reaction? Enzyme kinetics gives a quantitative answer when a model's assumptions fit. For an illustrative reaction obeying Michaelis-Menten kinetics, use the Michaelis-Menten equation with substrate concentration $s$, limiting reaction rate $V_{\max }$ and Michaelis constant $K_M$. At $s/K_M=0.1$, substitution gives $v/V_{\max }=0.1/1.1=1/11\approx 0.0909$. At $s/K_M=1$, it gives $1/2$; at $s/K_M=10$, it gives $10/11\approx 0.9091$. Thus a hundredfold increase in substrate between the first and last examples yields only a tenfold increase in reaction rate.

For a chosen $V_{\max }=110\mu \mathrm{M}\mathrm{mi}{\mathrm{n}}^{-1}$, those fractions mean reaction rates of $10$, $55$ and $100\mu \mathrm{M}\mathrm{mi}{\mathrm{n}}^{-1}$. Doubling substrate from $10K_M$ to $20K_M$ raises the normalized rate only from $10/11$ to $20/21\approx 0.9524$, a relative increase of about $4.76\%$. In this simplest model, the catalytic machinery is already nearly fully occupied. Doubling the amount of active enzyme instead doubles $V_{\max }$ and the predicted reaction rates at fixed free substrate concentration, provided the other conditions are unchanged. This distinction helps decide whether additional substrate or additional catalytic capacity could improve throughput.

The interpretation has limits. The simplest Michaelis-Menten kinetics assumes a single substrate, fixed active enzyme amount, a suitable quasi-steady-state approximation, and initial measurements with negligible reverse reaction from accumulated reaction product. Substantial depletion, interacting binding sites, or inhibition by excess substrate can invalidate this model. Within it, $K_M$ is the substrate concentration giving half the limiting reaction rate; it is not generally the binding dissociation constant $K_d$. See IUBMB, enzyme kinetics: steady-state approximation and substrate dissociation and IUBMB, Michaelis-Menten and non-Michaelis-Menten kinetics. Measuring activity also requires specified temperature, pH and necessary cofactor availability: a weak signal can reflect unsuitable conditions rather than little enzyme. See Brooks et al., Assay Guidance Manual: basics of enzymatic assays for HTS.

Glycolysis converts one glucose into two pyruvates, yielding two net ATP and reducing two NAD+ to two NADH in the canonical pathway. It first spends two ATP, then produces four by substrate-level phosphorylation. The pathway itself consumes no molecular oxygen; sustained operation nevertheless requires regeneration of NAD+.^[ref]

The useful organizing idea is three separate ledgers: carbon chemical atoms, transfers between ADP and ATP, and redox transfers between NAD+ and NADH. Splitting the carbon skeleton doubles the number of downstream conversions; recycling a cofactor permits repeated operation. These counts explain the yield without memorizing a drawing of every enzyme. The two net ATP belong to glycolysis alone, not to complete cellular respiration.

Y91F implicates the Tyr hydroxyl, while E57Q implicates the Glu carboxylic-acid chemistry. Replacing tyrosine by phenylalanine retains an aromatic side chain but removes its hydroxyl, supporting a role for Tyr91 as a hydrogen bond donor that polarizes the steroid C3 carbonyl and stabilizes an enolate-like intermediate or transition state. Its hydroxyl could participate in a proton relay, but inactivity alone does not establish that it supplies the final proton.

Replacing a glutamate residue by glutamine approximately preserves side-chain size while replacing a titratable carboxylic acid by an amide. Loss of activity, combined with the acidic activity range, supports protonated Glu57 as a carbonyl-activating acid and possible proton donor. The two residues can cooperate to stabilize oxygen charge during reduction. The inhibitor-binding structure supports local contacts; it is not a direct picture of a testosterone transition state, and an N–H contact of the aza inhibitor need not occur in testosterone.

To distinguish these chemical roles from indirect effects, compare mutant and wild-type abundance, membrane insertion and folding, cofactor binding, and steroid binding. Measure initial rates with matched enzyme amounts and include no-enzyme and inhibitor-treated wild-type controls. If binding survives but turnover fails, the evidence for a catalytic defect is stronger. The published study combines structure, mutagenesis and modeled testosterone placement, so the proposed residue roles should be distinguished from direct observation of proton trajectories.^[ref]

catalysis requires a protonated group, consistent with a general-acid contribution. Loss of its proton as pH rises would remove carbonyl activation or the proton needed to finish the conjugate reduction. A glutamate residue with a shifted active-site $p{K}_a$ is a plausible candidate, but a pH cutoff alone neither identifies the residue nor measures a precise $p{K}_a$. Irreversible unfolding or changes in substrate binding must also be excluded by reversible pH jumps, protein-integrity checks and initial-rate measurements.

For the mechanistic notation below, the reduced cofactor is written NADPH, the established cofactor of human steroid 5α-reductase. The original PDF explicitly labels it NADH; its abbreviated N-substituent does not display the phosphate distinction. NADH and NADPH have the same reactive reduced nicotinamide ring, so the local hydride-transfer arrows are unchanged, although their biochemical specificity is different.^[ref]